SCHEMBL20612065

SCHEMBL20612065

CCC(C)Nc1ccnc(Cl)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCAR3 P49019 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ HSP90AA1 P07900 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CCR4 P51679 4/20 0.42
▸ MAPK14 Q16539 3/20 0.41
▸ LRRK2 Q5S007 1/20 0.39
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28277650 1.00 HCAR3 (0.43) HCAR3ALDH1A1TP53HSP90AA1CYP3A4
SCHEMBL20956373 0.85 CCR4 (0.36) CCR4ESR1
SCHEMBL29607425 0.84 CRHR1 (0.42) HCAR3CCR4ESR1
SCHEMBL28937980 0.84 CRHR1 (0.42) HCAR3CCR4ESR1
SCHEMBL1774897 0.82 GAA (0.42) HCAR3TDP1MAPK14ESR1
SCHEMBL21550282 0.80 ESR1 (0.35) ALDH1A1SMN1; SMN2TDP1CCR4MAPK14
SCHEMBL20685774 0.80 MAPK14 (0.42) HCAR3MAPK14ESR1
SCHEMBL19692970 0.79 FYN (0.44) ALDH1A1SMN1; SMN2MAPK14MEN1NPC1
SCHEMBL21378510 0.79 FYN (0.44) ALDH1A1SMN1; SMN2MAPK14MEN1NPC1
SCHEMBL5756104 0.79 GRM5 (0.36) TDP1MAPK14ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3421465-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF Beijing Tide Pharmaceutical Co., Ltd. (CN) 2019-01-02 — — EP disclosed
Send feedback